H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Census population 134,023. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Haven clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Haven storefront.
Wharton's Jelly Allograft Products in New Haven, CT for clinics & physicians. Wharton's jelly allografts r… Compliance support & pricing — contact Hawk Medical.
New Haven is a city under 250k (134,023 Census). CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Adult arthritis here is 20.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Wharton's Jelly Allograft Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Adult obesity in New Haven is 37.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 20.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JK / National Government Services (NGS), sibling states MA, ME, NH, NY, RI, VT. Connecticut Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JK articles mapped. 14.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 11.7% of adults — 0.3 points below the U.S. 12% figure. Obesity is 37.9%; arthritis is 20.3%. That is place-level BRFSS modeling, not a clinic census and not a New Haven trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Connecticut compliance risk.
No. National Government Services (NGS) writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
No. They are B2B distribution pages for licensed providers. Patients in New Haven should speak with their clinician, not use a distributor URL as care instructions.
If you operate in Connecticut and another MAC state, say it on the first call. JK will not port 1:1. We would rather split utilization than watch a sister clinic copy New Haven tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in New Haven, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Haven is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Haven — 0.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Haven. Useful for joint-program math; still needs a diagnosis and privileging.
No New Haven storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.